The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, September 03, 2019
SutroVax received an award from CARB-X to develop a universal vaccine to prevent infections caused by Group A Strep bacteria, which include ...
read more
Thursday, September 05, 2019
ZyVersa announced advancements in development of our lead inflammasome inhibitor candidate, IC 100.
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat ...
read more
Tuesday, September 24, 2019
Over the past few years we’ve witnessed new medical breakthroughs that are altering how diseases are treated in ways that seemed unimaginable just a ...
read more
The FDA has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of ...
read more
The Allen Institute released its first dataset of electrical brain activity gathered using Neuropixels, a new high-resolution silicon probe that can ...
read more
Wednesday, October 16, 2019
Denovo Biopharma has announced FDA's approval to initiate a Phase 2b clinical study of DB102 in patients with newly-diagnosed glioblastoma in ...
read more
ProMIS Neurosciences continues to further develop antibody candidates that have shown selectivity for the toxic forms of tau.
read more
Tuesday, October 22, 2019
The NIH has awarded Matthew David Taylor, MD a four-year grant to determine whether prior infections change how the body responds to sepsis.
read more
Friday, November 01, 2019
Rutgers has been designated as a NIH's REACH program to speed up the commercialization of biomedical discoveries into viable diagnostics.
read more
Friday, November 01, 2019
Regen BioPharma announced new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in ...
read more
Thursday, November 07, 2019
Abbott has announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L...
read more
Tuesday, November 19, 2019
Kadimastem announced successful results of its preclinical proof-of-concept study of IsletRx, an "off-the-shelf" cell product for the treatment of ...
read more
Wednesday, November 20, 2019
Dicerna and Novo Nordisk announced an agreement to discover and develop novel therapies for the treatment of liver-related cardio-metabolic diseases ...
read more
Friday, December 06, 2019
CenExel Clinical Research has announced the acquisition of Research Centers of America (RCA) in Hollywood, FL.
read more